Evogene Ltd.EVGNNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank5
Year-over-Year Change
Year-over-year revenue growth rate
Percentile
P5
Near historical low
vs 5Y Ago
-10.7x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -64.71% |
| Q2 2025 | -63.83% |
| Q1 2025 | 51.71% |
| Q4 2024 | -7.41% |
| Q3 2024 | 187.60% |
| Q2 2024 | -85.56% |
| Q1 2024 | 624.91% |
| Q4 2023 | -84.66% |
| Q3 2023 | 475.99% |
| Q2 2023 | 2.03% |
| Q1 2023 | -2.88% |
| Q4 2022 | 41.63% |
| Q3 2022 | 49.36% |
| Q2 2022 | 31.65% |
| Q1 2022 | -23.79% |
| Q4 2021 | 105.96% |
| Q3 2021 | 11.85% |
| Q2 2021 | -59.46% |
| Q1 2021 | -5.13% |
| Q4 2020 | 11.08% |
| Q3 2020 | 6.04% |
| Q2 2020 | 297.33% |
| Q1 2020 | -35.34% |
| Q4 2019 | 19.59% |
| Q3 2019 | -49.48% |
| Q2 2019 | -44.83% |
| Q1 2019 | -45.20% |
| Q4 2018 | 73.02% |
| Q3 2018 | -3.17% |
| Q2 2018 | 3.55% |
| Q1 2018 | -50.14% |
| Q4 2017 | -1.87% |
| Q3 2017 | -36.50% |
| Q2 2017 | 63.38% |
| Q1 2017 | -38.90% |
| Q4 2016 | -23.18% |
| Q3 2016 | -15.04% |
| Q2 2016 | -10.32% |
| Q1 2016 | -18.15% |
| Q4 2015 | -25.57% |